Author: OurCrowd

[Alloy Therapeutics in BusinessWire] Alloy Therapeutics announces acquisition of Spannerwerks, a leading provider of drug development consulting services

Oct 23, 2025 |

BOSTON–(BUSINESS WIRE)–Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced the acquisition of Spannerwerks, LLC, a Seattle-based professional services firm that guides biopharmaceutical companies on the development and launch of new products. Read more...

Read More

[OncoHost in PR Newswire] OncoHost receives New York StatelLaboratory permit, expanding availability of PROphetNSCLC® precision oncology test

Oct 22, 2025 |

BINYAMINA, Israel and CARY, N.C., Oct. 22, 2025 /PRNewswire/ — OncoHost, a technology company transforming the approach to precision medicine through plasma proteomics and AI, today announced that it has received a laboratory permit from the New York State Department of Health Wadsworth Center. This permit enables the company to offer its PROphetNSCLC® test to physicians and patients across New York State, marking a key milestone in OncoHost’s U.S. expansion. Read more...

Read More

[Liquid Instruments in Electronic Design] Talking about advanced test

Oct 21, 2025 |

The world of test & measurement is getting more complex and challenging in many ways. Multiple factors continue to impact the T&M industry, from materials to new topologies to smaller form factors with even higher levels of integration and power density. All of these aspects must be thoroughly tested in a device to ensure safe, efficient, and reliable operation. Read more...

Read More